Celerion is a global leader in early clinical research services, focusing on translating scientific advances into innovative human health solutions. With a strong emphasis on conducting early phase clinical trials, they provide comprehensive services in areas such as pharmacokinetics, biostatistics, data management, and bioanalysis. Celerion utilizes state-of-the-art technology and scientific expertise to conduct clinically-rich pharmacology studies, enabling efficient and effective drug development. Their facilities are strategically located in North America, Europe, and Asia, allowing them to cater to clients worldwide across various therapeutic areas.